journal article·2024-02-13

Whole-Body and Whole-Organ 3D Imaging of Hypoxia Using an Activatable Covalent Fluorescent Probe Compatible with Tissue Clearing

Daichi M. Sakamoto, Iori Tamura, Bo Yi, Sho Hasegawa, Yutaro Saito, Naoki Yamada, Yoichi Takakusagi, Shimpei I. Kubota, Minoru Kobayashi, Hiroshi Harada, Kenjiro Hanaoka, Masayasu Taki, Masaomi Nangaku, Kazuki Tainaka, Shinsuke Sando

ACS Nano· Volume 18· Issue 6
Publisher page

Abstract

Elucidation of biological phenomena requires imaging of microenvironments in vivo. Although the seamless visualization of in vivo hypoxia from the level of whole-body to single-cell has great potential to discover unknown phenomena in biological and medical fields, no methodology for achieving it has been established thus far. Here, we report the whole-body and whole-organ imaging of hypoxia, an important microenvironment, at single-cell resolution using activatable covalent fluorescent probes compatible with tissue clearing. We initially focused on overcoming the incompatibility of fluorescent dyes and refractive index matching solutions (RIMSs), which has greatly hindered the development of fluorescent molecular probes in the field of tissue clearing. The fluorescent dyes compatible with RIMS were then incorporated into the development of activatable covalent fluorescent probes for hypoxia. We combined the probes with tissue clearing, achieving comprehensive single-cell-resolution imaging of hypoxia in a whole mouse body and whole organs.
Source: europepmc · Quality: candidate unverified · Source record ↗

Research context

OpenAlex topics: Nanoplatforms for cancer theranostics · Cancer, Hypoxia, and Metabolism · Advanced Fluorescence Microscopy Techniques

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

Affiliations

Department of Chemistry and Biotechnology, Graduate School of Engineering, The University of Tokyo, 7-3-1 Hongo, Bunkyo-ku, Tokyo 113-8656, Japan

Division of Nephrology and Endocrinology, Graduate School of Medicine, The University of Tokyo, 7-3-1 Hongo, Bunkyo-ku, Tokyo 113-8654, Japan

Quantum Hyperpolarized MRI Team, Institute for Quantum Life Science, National Institutes for Quantum Science and Technology, 4-9-1 Anagawa, Inage, Chiba-city 263-8555, Japan

Institute for Quantum Medical Science, National Institutes for Quantum Science and Technology, 4-9-1 Anagawa, Inage, Chiba-city 263-8555, Japan

Division of Molecular Psychoimmunology, Institute for Genetic Medicine, Graduate School of Medicine, Hokkaido University, Kita-15, Nishi-7, Kita-ku, Sapporo, Hokkaido 060-0815, Japan

Laboratory of Cancer Cell Biology, Graduate School of Biostudies, Kyoto University, Yoshida Konoe-cho, Sakyo-ku, Kyoto 606-8501, Japan

Department of Genome Dynamics, Radiation Biology Center, Graduate School of Biostudies, Kyoto University, Yoshida Konoe-cho, Sakyo-ku, Kyoto 606-8501, Japan

Division of Analytical Chemistry for Drug Discovery, Graduate School of Pharmaceutical Sciences, Keio University, 1-5-30 Shibakoen, Minato-ku, Tokyo 105-8512, Japan

Institute of Transformative Bio-Molecules, Nagoya University, Furo, Chikusa, Nagoya 464-8601, Japan

Department of System Pathology for Neurological Disorders, Brain Research Institute, Niigata University, 1-757 Asahimachidori, Chuo-ku, Niigata 951-8585, Japan

Gftd DeSci, Gftd DAO, Nishikawa Building, 20 Kikuicho, Shinjuku-ku, Tokyo 162-0044, Japan

Department of Bioengineering, Graduate School of Engineering, The University of Tokyo, 7-3-1 Hongo, Bunkyo-ku, Tokyo 113-8656, Japan

Funding

Ministry of Education, Culture, Sports, Science and Technology · Japan Agency for Medical Research and Development · Japan Society for the Promotion of Science · Precise Measurement Technology Promotion Foundation

References (69)

Show source-provided references
1. 10.1038/s41578-022-00426-z10.1038/s41578-022-00426-z ↗
2. 10.1038/s41571-021-00539-410.1038/s41571-021-00539-4 ↗
3. 10.1039/D1CS00083G10.1039/D1CS00083G ↗
4. 10.1007/s10522-020-09888-610.1007/s10522-020-09888-6 ↗
5. 10.1021/acs.inorgchem.9b0122110.1021/acs.inorgchem.9b01221 ↗
6. 10.1039/D0SC03096A10.1039/D0SC03096A ↗
7. 10.1016/j.addr.2021.04.00110.1016/j.addr.2021.04.001 ↗
8. 10.1038/s42255-019-0105-010.1038/s42255-019-0105-0 ↗
9. 10.1039/D1CS00645B10.1039/D1CS00645B ↗
10. 10.1002/agt2.11510.1002/agt2.115 ↗
11. 10.1002/anie.20190969010.1002/anie.201909690 ↗
12. 10.1021/acs.accounts.9b0034010.1021/acs.accounts.9b00340 ↗
13. 10.1038/s41467-021-22855-010.1038/s41467-021-22855-0 ↗
14. 10.1021/acs.inorgchem.1c0177910.1021/acs.inorgchem.1c01779 ↗
15. 10.1016/j.snb.2021.13039310.1016/j.snb.2021.130393 ↗
16. 10.1021/acs.analchem.9b0400210.1021/acs.analchem.9b04002 ↗
17. 10.1039/D0SC04789A10.1039/D0SC04789A ↗
18. 10.1111/php.1315510.1111/php.13155 ↗
19. 10.1038/s43586-021-00080-910.1038/s43586-021-00080-9 ↗
20. 10.1002/jbio.20200041310.1002/jbio.202000413 ↗
21. 10.1038/s41467-020-15906-510.1038/s41467-020-15906-5 ↗
22. 10.1016/j.cell.2019.11.01310.1016/j.cell.2019.11.013 ↗
23. 10.1016/j.cell.2014.07.01710.1016/j.cell.2014.07.017 ↗
24. 10.1016/j.cell.2014.10.03410.1016/j.cell.2014.10.034 ↗
25. 10.1038/s41598-022-09303-910.1038/s41598-022-09303-9 ↗
26. 10.1126/sciadv.aau835510.1126/sciadv.aau8355 ↗
27. 10.1038/s41467-018-03359-w10.1038/s41467-018-03359-w ↗
28. 10.1016/j.chempr.2022.11.00510.1016/j.chempr.2022.11.005 ↗
29. 10.1126/sciadv.aba454210.1126/sciadv.aba4542 ↗
30. 10.3390/pharmaceutics1211107010.3390/pharmaceutics12111070 ↗
31. 10.1021/bc500400z10.1021/bc500400z ↗
32. 10.1021/bc200470410.1021/bc2004704 ↗
33. 10.1021/jacs.0c0254710.1021/jacs.0c02547 ↗
34. 10.1021/jacs.0c0572710.1021/jacs.0c05727 ↗
35. 10.1038/nmeth103610.1038/nmeth1036 ↗
36. 10.1016/j.celrep.2018.07.05610.1016/j.celrep.2018.07.056 ↗
37. 10.3390/ijms2123921710.3390/ijms21239217 ↗
38. 10.1007/s41061-020-00323-510.1007/s41061-020-00323-5 ↗
39. 10.1038/s41596-019-0240-910.1038/s41596-019-0240-9 ↗
40. 10.1021/ol062392610.1021/ol0623926 ↗
41. 10.1021/ja043919h10.1021/ja043919h ↗
42. 10.1016/0003-2697(92)90011-U10.1016/0003-2697(92)90011-U ↗
43. 10.1021/acs.bioconjchem.9b0037510.1021/acs.bioconjchem.9b00375 ↗
44. 10.1021/acs.bioconjchem.8b0084510.1021/acs.bioconjchem.8b00845 ↗
45. 10.1021/cb100241610.1021/cb1002416 ↗
46. 10.1002/anie.20180473110.1002/anie.201804731 ↗
47. 10.1021/ja00096a04210.1021/ja00096a042 ↗
48. 10.1038/s41467-022-30925-010.1038/s41467-022-30925-0 ↗
49. 10.1007/s00125-021-05380-z10.1007/s00125-021-05380-z ↗
50. 10.1016/j.arr.2021.10134310.1016/j.arr.2021.101343 ↗
51. 10.1038/s41580-020-0227-y10.1038/s41580-020-0227-y ↗
52. 10.1016/j.devcel.2019.05.02510.1016/j.devcel.2019.05.025 ↗
53. 10.1046/j.1432-1327.1998.2530743.x10.1046/j.1432-1327.1998.2530743.x ↗
54. 10.1681/ASN.201208085510.1681/ASN.2012080855 ↗
55. 10.1080/02549948.1993.1173124810.1080/02549948.1993.11731248 ↗
56. 10.1152/ajprenal.00590.201910.1152/ajprenal.00590.2019 ↗
57. 10.1152/ajprenal.00219.201910.1152/ajprenal.00219.2019 ↗
58. 10.1016/j.bmcl.2019.05.04910.1016/j.bmcl.2019.05.049 ↗
59. 10.7554/eLife.7741910.7554/eLife.77419 ↗
60. 10.2144/btn-2020-015210.2144/btn-2020-0152 ↗
61. 10.1038/s41598-020-76878-610.1038/s41598-020-76878-6 ↗
62. 10.1093/bja/aeh11210.1093/bja/aeh112 ↗
63. Kaanders J. H. A. M. · Cancer Res. · 2002 · 62 · 7066
64. 10.4049/jimmunol.167.11.614010.4049/jimmunol.167.11.6140 ↗
65. 10.1007/978-1-59745-352-3_1210.1007/978-1-59745-352-3_12 ↗
66. 10.1007/s00418-007-0324-410.1007/s00418-007-0324-4 ↗
67. 10.1038/s41598-018-25804-y10.1038/s41598-018-25804-y ↗
68. 10.1016/j.cmet.2016.09.00810.1016/j.cmet.2016.09.008 ↗
69. 10.3109/0284186X.2013.81579710.3109/0284186X.2013.815797 ↗